Paolo Cioffi, MD

Treatment of Common Femoral Artery Lesions Involving the Superficial and Profunda Femoral Artery Bifurcation: Is the Snow Too Melted to Plow With New Endovascular Devices?

Treatment of Common Femoral Artery Lesions Involving the Superficial and Profunda Femoral Artery Bifurcation: Is the Snow Too Melted to Plow With New Endovascular Devices?

05/21/2020

Giuseppe Celano , MD;

Sante Bongo , MD;

Gaetano Chiricolo , MD;

Alberto Francesco Cereda , MD;

Giueseppe Massimo Sangiorgi , MD, PhD;

Paolo Cioffi , MD;

Riccardo Iorio , MD;

Attilio Cotroneo , MD;

Herein, we have reported two cases at high risk for surgical CFE treated respectively with directional atherectomy and intravascular lithotripsy, with good clinical success both in short- and long-term follow-up.

Herein, we have reported two cases at high risk for surgical CFE treated respectively with directional atherectomy and intravascular lithotripsy, with good clinical success both in short- and long-term follow-up.

Herein, we have reported two...

05/21/2020

Cath Lab Digest

Treatment of Common Femoral Artery Lesions Involving the Superficial and Profunda Femoral Artery Bifurcation

Original Research

Treatment of Common Femoral Artery Lesions Involving the Superficial and Profunda Femoral Artery Bifurcation

05/15/2020

Riccardo Iorio , MD;

Attilio Cotroneo , MD;

Giuseppe Celano , MD;

Sante Bongo , MD;

Gaetano Chiricolo , MD;

Alberto Francesco Cereda , MD;

Giueseppe Massimo Sangiorgi , MD, PhD;

Paolo Cioffi , MD;

The authors repot on 2 cases at high risk for surgical CFE treated respectively with directional atherectomy and intravascular lithotripsy, with good clinical success both in short- and long-term follow-up.

The authors repot on 2 cases at high risk for surgical CFE treated respectively with directional atherectomy and intravascular lithotripsy, with good clinical success both in short- and long-term follow-up.

The authors repot on 2 cases at...

05/15/2020

Vascular Disease Management

Featured CME Course

Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes

Upcoming Events

February 2 ⁠–⁠ February 5

February 7 ⁠–⁠ February 9

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

March 22 ⁠–⁠ March 23

NP Institute

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

WoundCon

May 1 ⁠–⁠ May 3

See Full Calendar